Search research articles
Contact Us
Filters
Showing results (41-50 of 290) with videos related to
Page
of 29
Sort By:
La Clinica Terapeutica
|
September 30, 1977
[Comparison of tolerability and clinical efficacy of acetylsalicylic acid and a new nonsteroid anti-inflammatory drug in osteoarthritis]
A Debolini, R Marcolongo, G Granelli
International Journal of Clinical Pharmacology and Biopharmacy
|
November 1, 1978
Hypotriglyceridemic effect of chenodeoxycholic acid after a short time of administration
E Camarri, R Marcolongo, F Fici
Reumatismo
|
January 1, 1975
[Behavior of 5-phosphoribosyl-1-pyrophosphate (PRPP) in erythrocytes, leukocytes and lymphocytes of normal and gouty subjects]
G Pompucci, V Micheli, R Marcolongo
Advances in Experimental Medicine and Biology
|
January 1, 1980
Ribose tolerance in gouty patients
M Pizzichini, R Marcolongo, E Marinello
Lancet (London, England)
|
December 1, 1973
Letter: HB antigen in saliva
R Marcolongo, A Debolini, A Barberi
Annals of the New York Academy of Sciences
|
October 4, 2007
Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects
S Tognon, G Graziani, R Marcolongo
Minerva Medica
|
June 23, 1983
[Short-term effects of proglumetacin in arthrosis]
R Marcolongo, N Giordano, A Fioravanti
British Journal of Haematology
|
August 1, 1995
Thrombocytopenic purpura following treatment with danazol
F Laveder, R Marcolongo, S Zamboni
Giornale Italiano Di Cardiologia
|
February 1, 1993
[Pulmonary thromboembolism and thrombolytics in pregnancy: a clinical case report and review of the literature]
R Russo, R Marcolongo, L Schivazappa
Advances in Experimental Medicine and Biology
|
January 1, 1977
Familial distribution of increased erythrocyte PP-ribose-P levels
R Marcolongo, G Pompucci, V Micheli
Page
of 29
Search research articles
Search
Showing results (41-50 of 290) with videos related to
Sort By:
Page
of 29
La Clinica Terapeutica
|
September 30, 1977
[Comparison of tolerability and clinical efficacy of acetylsalicylic acid and a new nonsteroid anti-inflammatory drug in osteoarthritis]
A Debolini, R Marcolongo, G Granelli
International Journal of Clinical Pharmacology and Biopharmacy
|
November 1, 1978
Hypotriglyceridemic effect of chenodeoxycholic acid after a short time of administration
E Camarri, R Marcolongo, F Fici
Reumatismo
|
January 1, 1975
[Behavior of 5-phosphoribosyl-1-pyrophosphate (PRPP) in erythrocytes, leukocytes and lymphocytes of normal and gouty subjects]
G Pompucci, V Micheli, R Marcolongo
Advances in Experimental Medicine and Biology
|
January 1, 1980
Ribose tolerance in gouty patients
M Pizzichini, R Marcolongo, E Marinello
Lancet (London, England)
|
December 1, 1973
Letter: HB antigen in saliva
R Marcolongo, A Debolini, A Barberi
Annals of the New York Academy of Sciences
|
October 4, 2007
Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects
S Tognon, G Graziani, R Marcolongo
Minerva Medica
|
June 23, 1983
[Short-term effects of proglumetacin in arthrosis]
R Marcolongo, N Giordano, A Fioravanti
British Journal of Haematology
|
August 1, 1995
Thrombocytopenic purpura following treatment with danazol
F Laveder, R Marcolongo, S Zamboni
Giornale Italiano Di Cardiologia
|
February 1, 1993
[Pulmonary thromboembolism and thrombolytics in pregnancy: a clinical case report and review of the literature]
R Russo, R Marcolongo, L Schivazappa
Advances in Experimental Medicine and Biology
|
January 1, 1977
Familial distribution of increased erythrocyte PP-ribose-P levels
R Marcolongo, G Pompucci, V Micheli
Page
of 29